Data Science Services

Experts in data science achieve new levels of insight through real world data (RWD), advanced analytics, and interactive visualizations.

Thank you to the MMS team for great teamwork, effort, and commitment. We appreciate it!
Dir, Clinical Development
Small Pharma Sponsor

The Data Science experts at MMS open new possibilities for Sponsors searching for data-driven insights for pharmaceutical, biotech, and healthcare organizations. We employ a wealth of regulatory expertise, strong processes, and purpose-built, flexible data visualization technology to drive efficiency using real world data (RWD).
 
This leads to uncovering new insights on disease, compound, patient, and possible operational improvements for those involved in life-sciences and clinical research.
 
When engaging MMS, Sponsors have gained immense value, including but not limited to:

  • Efficiency in clinical development, using near real-time, interactive data visualization to drive program-critical decisions
  • Reimagined solutions for complex regulatory questions, through the combined use of industry expertise, strong processes, and integrated technology
  • Curating non-traditional data sources and building a framework for exploration, leading to new treatments and label expansion
  • Leveraging the expertise of MMS data scientists to support data-driven objectives through project based or FSP models

The sections below detail comprehensive Data Science solutions, including consulting, technology, and functional solutions staffing. Request a consultation with a Data Science expert and learn why MMS is the data science CRO of choice for innovative life science teams and organizations.

Planning & Consulting

Data Science discovery is foundational for planning the use of real-world data (RWD) to answer organizational objectives and improve business decisions. Add words. Through a purposeful approach, MMS data science experts will work to define the strategic goals for a data science engagement, including identification of appropriate data to pair with data available from clinical trials.

In the tree diagram below, Sponsors can view how RWD flows from the roots into usable insights and real-world evidence (RWE) at the leaves.

Data Science Services Editable

 

Data Curation

Data Scientists at MMS are proficient in the abstraction and preparation of data from any source for analysis and/or visualization. At times, this may require creation of a database or data lake to store data, with sources that may include Electronic Health Records (EHR), wearables or other health devices, social media, medical claims, and others. ​

Here are a few ways that Sponsors can engage MMS:

  • Data curation, including relationships with data brokers/source(s) to collect and prepare for analysis​
  • Intake and standardization of streaming data (i.e. wearables)​
  • Curation of EHR data for retrospective analysis to support label expansion​

To aid in data curation, MMS utilizes Datacise® CURATE, a flexible cloud-based application for the collection and aggregation of clinical data through a variety of data mapping or abstraction methods.

Learn more about this scalable platform.

Advanced Analytics

Data Scientists at MMS can provide Sponsors with a deeper understanding of data through custom algorithms and advanced analytical models. This support may include machine learning (ML), natural language processing (NLP), and data mining or web scraping. Our approach allows for complex statistical methodology and novel programming languages, including Julia, Python, R, and others. ​

Here are a few ways that Sponsors can engage MMS:

  • Natural language processing of Twitter and Reddit posts to extract drug product related content for safety​ surveillance
  • ML-based detection of clinically important subgroups (i.e. data mining)​
  • Location-based analyses (i.e. GPS and wearables)​ and compliance reporting
  • Image recognition and analysis
  • Complex exploratory models

To aid in advanced analytics, MMS utilizes Datacise® ANALYZE, a fully-integrated cloud-based technology platform that supports advanced analytical needs for RWD and other data. For this, we collaborate with SME statisticians towards customizing the end-user dashboard for optimal usefulness ad accurate modeling in the background. This may be the case if including a Kaplan-meier survival plot or Mixed Model Repeated Measures [MMRM] inferential statistics, for instance.

Learn more about this scalable platform.

Data Visualization

Data Scientists at MMS provide Sponsors with rapid data insights through browser-based interactive dashboards. With the potential for API data extraction into dashboards, Sponsors can take advantage of automated data refreshes, reports, and alerts to ensure that data is always up-to-date.​

Here are a few ways that Sponsors can engage MMS for visualization support:

  • DSMB and Adjudication meetings including dashboards to augment static tables and listings
  • Patient profiles to aid in ongoing safety reviews and assessments
  • Dashboards for medical device and wearables data
  • Site performance dashboards that help clinical teams and data managers monitor study progress
  • Safety surveillance signal detection, using social media and regulatory data sources (i.e. FAERS)

To aid in data visualization, MMS utilizes Datacise® EXPLORE, a fully-integrated cloud-based technology platform that provides integrated data visualizations and dashboards to support analysis, review, and ultimately, speed decision-making, without having to wait for programming of “ad-hoc” tables and listings.

Learn more about this scalable platform.

Functional Service Provision (FSP) Support Models

Sponsors around the globe engage with MMS for FSP partnerships in the area of Data Science. Our FSP models are designed to be flexible and scalable, allowing our team and level of engagement to smoothly shift with your changing needs.

Key benefits to engaging in an FSP model with our data scientists include:

  • Experience and consistency of an FSP relationship allows MMS to bring the greatest value, rather than other transactional models
  • Effective and efficient communication plans by defining roles and responsibilities, with a clear escalation process
  • Efficiency gains through interdependent cross-functional services

Through value-added FSP partnerships, MMS strives for seamless collaborations that build trust. Learn more about our FSP model.

Suggested For You

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval

webinar

September 12th, 2024

No Stone Unturned: Optimizing the Use of Expedited Pathways and Oncology Center of Excellence Programs to Optimize Drug Development in Oncology

regulatory intelligence

August 9th, 2024

FDA Updates 2024 Language Access Plan

regulatory intelligence

August 3rd, 2024

EMA Launches New Pilot Program for Orphan Medical Devices

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

regulatory intelligence

July 26th, 2024

Key Decision Points for Recent Oncology Approvals

regulatory intelligence

July 24th, 2024

Comments Open for Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization